Stock Earnings

Question 1

PTC Therapeutics Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, PTC Therapeutics Inc'in toplam varlıkları $1,705 olup, net loss $-363'dir.

Question 2

PTCT'ün temel finansal oranları nelerdir?

Accepted Answer

PTC Therapeutics Inc'in cari oranı 0.6, net kâr marjı -45.03, hisse başına satış $10.48'dir.

Question 3

PTC Therapeutics Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

PTC Therapeutics Inc largest revenue segment is Life Science, at a revenue of 806,780,000 in the most earnings release.For geography, United States is the primary market for PTC Therapeutics Inc, at a revenue of 413,044,000.

Question 4

PTC Therapeutics Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre PTC Therapeutics Inc'in net loss $-363'dir.

Question 5

PTC Therapeutics Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, PTC Therapeutics Inc'in yükümlülüğü 2,803'dir.

Question 6

PTC Therapeutics Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

PTC Therapeutics Inc'in toplam tedavüldeki hisse sayısı 77.7'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,764	806	937	698	538	380
Revenue Growth (YoY)	96%	-14%	34%	30%	42%	24%
Cost of Revenue	51	57	65	44	32	18
Gross Profit	1,713	749	872	654	506	361
Selling, General & Admin	324	300	332	326	285	245
Research & Development	508	534	666	651	540	477
Operating Expenses	836	891	1,094	1,068	880	783
Other Non Operating Income (Expenses)	11	8	6	-30	-43	85
Pretax Income	666	-363	-696	-587	-518	-402
Income Tax Expense	36	0	-69	-28	5	35
Net Income	629	-363	-626	-559	-523	-438
Net Income Growth	-231%	-42%	12%	7%	19%	75%
Shares Outstanding (Diluted)	78.15	76.84	74.83	71.7	70.5	66
Shares Change (YoY)	2%	3%	4%	2%	7%	12%
EPS (Diluted)	8.05	-4.72	-8.37	-7.79	-7.43	-6.64
EPS Growth	-229%	-44%	7%	5%	12%	56%
Free Cash Flow	697	-114	-186	-388	-279	-211
Free Cash Flow Per Share	8.91	-1.48	-2.48	-5.41	-3.95	-3.19
Gross Margin	97.1%	92.92%	93.06%	93.69%	94.05%	95%
Operating Margin	49.71%	-17.61%	-23.58%	-59.31%	-69.51%	-110.78%
Profit Margin	35.65%	-45.03%	-66.8%	-80.08%	-97.21%	-115.26%
Free Cash Flow Margin	39.51%	-14.14%	-19.85%	-55.58%	-51.85%	-55.52%
EBITDA	905	-67	15	-286	-310	-378
EBITDA Margin	51.3%	-8.31%	1.6%	-40.97%	-57.62%	-99.47%
D&A For EBITDA	28	75	236	128	64	43
EBIT	877	-142	-221	-414	-374	-421
EBIT Margin	49.71%	-17.61%	-23.58%	-59.31%	-69.51%	-110.78%
Effective Tax Rate	5.4%	0%	9.91%	4.77%	-0.96%	-8.7%

PTC Therapeutics Inc (PTCT) Price

PTCT Stock Price Chart

PTCT Income

Follow-Up Questions